Pseudomyxoma peritonei screening: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Pseudomyxoma peritonei}} {{CMG}}; {{AE}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR According to...") |
Nima Nasiri (talk | contribs) |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for | There is insufficient evidence to recommend routine screening for pseudomyxoma peritonei. | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for [disease/malignancy]. | There is insufficient evidence to recommend routine screening for [disease/malignancy]. | ||
Revision as of 21:30, 14 January 2019
|
Pseudomyxoma peritonei Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pseudomyxoma peritonei screening On the Web |
|
American Roentgen Ray Society Images of Pseudomyxoma peritonei screening |
|
Risk calculators and risk factors for Pseudomyxoma peritonei screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for pseudomyxoma peritonei.
Screening
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]